Hematologic Neoplasms: all 1,496 studies
Page 2 of 15. Open to participants first (440), then studies with results posted, then the rest; newest registration first within each.
- A Phase I Study of QLS2309 Injection in Patients With CD70+ Relapsed/Refractory Hematologic MalignanciesRecruitingNCT07173595Phase 1
- Non-Pharmacological Interventions for Neurotoxicity in Hematologic Patients Receiving CAR-T TherapyRecruitingNCT07173166Not applicable
- Fecal Microbiota Transplantation Among Adult Patients With Hematological MalignanciesEnrolling by invitationNCT07172191Not applicable
- Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell TransplantationRecruitingNCT07162038Phase 1
- A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic MalignanciesRecruitingNCT07154823
- A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and VenetoclaxRecruitingNCT07148180Phase 1/2
- Virtual Reality Intervention for Symptom Management in Stem Cell TransplantationNot yet recruitingNCT07145359Not applicable
- Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological MalignanciesNot yet recruitingNCT07137481Phase 2
- Allergy Delabeling in Antibiotic Stewardship - InterventionRecruitingNCT07133074Phase 4
- A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in Adult Participants With Relapsed/Refractory CD19-positive B-cell Malignant Hematological TumorsRecruitingNCT07131254Early Phase 1
- 18F-Pentixafor PET in Hematologic MalignanciesRecruitingNCT07122674
- Home Blood TransfusionsRecruitingNCT07121140Not applicable
- A Clinical Study to Evaluate the Safety and Efficacy of Anti-human CD 7 CAR-NK Cell Injection in Subjects With Relapsed and Refractory CD7-positive Hematological MalignancyNot yet recruitingNCT07117175Early Phase 1
- ABO and Rh Blood Group Frequencies in Acute Leukemia PatientsNot yet recruitingNCT07108010
- A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic MalignanciesNot yet recruitingNCT07107204Phase 1/2
- Distraction With Virtual Reality From Pain and Anxiety for Patients With Hematological MalignanciesRecruitingNCT07085065Not applicable
- Lifestyle Intervention for Veterans With Blood Cancer: Tele-InterventionRecruitingNCT07058571Not applicable
- A Music Therapy Study for Blood Cancer Survivors With Cognitive DifficultiesRecruitingNCT07052916Not applicable
- TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic MalignanciesRecruitingNCT07052370Phase 1
- Prospective Study Evaluate the Timing of Empirical Treatment for Carbapenem-resistant Bacterials (CROEAT Study)Not yet recruitingNCT07047352Not applicable
- Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid MalignanciesRecruitingNCT07044544Phase 1
- Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer PatientsRecruitingNCT07043894Phase 2
- The Florida ASCENT StudyRecruitingNCT07042243Not applicable
- The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer ImmunotherapyRecruitingNCT07039474
- Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic ImpairmentRecruitingNCT07036133Phase 1
- T-cell Developmental Status in Patients With Malignant Hematological TumorsRecruitingNCT07035938
- Micro Assays for HemATology Malignancies Antibody TreatmentNot yet recruitingNCT07018310Not applicable
- Factors Associated With Health-related Quality of Life and Social Participation of Patients With Multiple Myeloma and Their CaregiversRecruitingNCT07014865
- Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT07014449Phase 1
- Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AMLRecruitingNCT07007312Phase 3
- A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell TransplantRecruitingNCT07006506Phase 2
- Immunological Impact of a Post Cell Therapy Treatment With FLT3 InhibitorsNot yet recruitingNCT06992934Not applicable
- Implementation of an Oral Chemotherapy Adherence InterventionRecruitingNCT06989489Not applicable
- DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET DysregulationsRecruitingNCT06988475Phase 2/3
- Allergy Delabeling in Antibiotic Stewardship - EvaluationsEnrolling by invitationNCT06967467
- Mosaic Trial for Stem Cell Transplant RecipientsRecruitingNCT06960993Not applicable
- GT719 Injection for the Treatment of Recurrent/Refractory CD19 Positive Adult B-cell MalignanciesRecruitingNCT06948981Phase 1/2
- Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD PreventionRecruitingNCT06926595Phase 2
- Follow-Up for Study Participants Treated With an Allogeneic CAR T Cell ProductEnrolling by invitationNCT06925685
- A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological MalignanciesRecruitingNCT06914037Phase 1
- Multidisciplinary Intervention for Adults With Chronic Graft-versus-host DiseaseRecruitingNCT06910969Not applicable
- Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic MalignanciesRecruitingNCT06909474Phase 1
- Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic MalignanciesRecruitingNCT06904066Phase 1
- Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult OncologyRecruitingNCT06897137
- Involvement of CDA and/or dCK Metabolizing Enzymes in the Response to Azacytidine Treatment of Patients With Hematologic MalignanciesRecruitingNCT06886425Not applicable
- Ocular Complications From Cancer Therapy - Patient Registry and BiobankRecruitingNCT06874283
- Time Restricted Eating in Haematological MalignanciesNot yet recruitingNCT06862323Phase 2
- Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantRecruitingNCT06856226
- Observational Study for the Evaluation of Immune-mediated Endocrinological Adverse Events in Patients with Hematological Malignancies and Subjected to Treatment with Immune-checkpoint InhibitorsRecruitingNCT06851702
- UNIVERSAL GENETIC TESTING OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES (UGT)Not yet recruitingNCT06843291Not applicable
- Early Clinical Study of JY306 Universal NK Cell Injection in the Treatment of Adult Relapsed or Refractory CD70+ Malignant Hematologic TumorsNot yet recruitingNCT06837389Early Phase 1
- A Study Evaluating the Value of 68Ga-Pentixafor PET Imaging in the Staging of Hematological Tumor, and Comparing It with 18F-FDG PET/CT ImagingRecruitingNCT06834412Not applicable
- Cryopreserved Ovarian Tissue Transplantation in Patients Who Have Survived Sarcomas and Hematological TumorsRecruitingNCT06829654Not applicable
- A Phase 1 Study of IM-1021 in Participants With Advanced CancerRecruitingNCT06823167Phase 1
- Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Hematological CancerNot yet recruitingNCT06817759Not applicable
- Safety and Feasibility of a Multidisciplinary Programme of Integrated Hospital-home Management with Early Discharge of Patients with Haematological Malignancies Undergoing High-dose Chemotherapy in HospitalRecruitingNCT06814405Not applicable
- Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell TransplantationRecruitingNCT06807606Phase 2
- Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell TransplantationRecruitingNCT06799195Phase 2
- A Study of the Effect of Laughter Therapy on the Mental Health and Quality of Survival of Hematopoietic Stem Cell Transplant PatientsNot yet recruitingNCT06792630Not applicable
- A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological TumorsRecruitingNCT06783816Not applicable
- A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)RecruitingNCT06782373Phase 2
- Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic MalignanciesRecruitingNCT06758713Phase 1
- This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.RecruitingNCT06756451Phase 1
- A Study of CAR T-Cells in Relapsed/Refractory Hematologic MalignancyRecruitingNCT06756321Early Phase 1
- The Microbiome in Blood Cancer and HLHNot yet recruitingNCT06734624
- RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell MalignanciesRecruitingNCT06732492Phase 1
- HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCTRecruitingNCT06731504Early Phase 1
- CD7-specific CAR-T Cell in the Treatment of CD7-positive Relapsed/Refractory Hematologic TumorsRecruitingNCT06720324Phase 1/2
- A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.RecruitingNCT06697184Phase 1/2
- Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBTRecruitingNCT06693791Phase 2
- Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular TherapyRecruitingNCT06689800Not applicable
- Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell TransplantationRecruitingNCT06676852Not applicable
- Using a Population Pharmacokinetic Model to Estimate the Dosage of Teicoplanin in Patients With Hematologic Malignancy or Critical IllnessNot yet recruitingNCT06674330
- PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)RecruitingNCT06665100Phase 2
- Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell TherapiesRecruitingNCT06652633Phase 3
- A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid TumorRecruitingNCT06615193Phase 1
- National Longitudinal Cohort of Hematological Diseases (NICHE) - CARTRecruitingNCT06607289
- Wearable Activity Tracking to Curb HospitalizationsRecruitingNCT06587100
- Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological TumorsRecruitingNCT06584006Phase 2
- Individualized First Maintenance Doses of Voriconazole Through a Multiparametric AlgorithmNot yet recruitingNCT06582186Phase 4
- Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell TherapyRecruitingNCT06579469
- Clinical Evaluation of the Scopio Cell Morphology TechnologyNot yet recruitingNCT06574308
- A Clinical Trial of TQB3455 Tablets in Patients With Hematological MalignanciesRecruitingNCT06550713Phase 1
- Drug Response Profiling (DRP) Registry Zurich for Hematological MalignanciesRecruitingNCT06550102
- Study of Posaconazole Prophylaxis in Patients Receiving Hematopoietic Stem Cell Allograft (Allo-HSC) at High Risk of Invasive Fungal Infection (IFI)RecruitingNCT06541067Phase 2
- Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient TreatmentRecruitingNCT06532773Not applicable
- Safety, Tolerability and Preliminary Efficacy of Erythrocyte-αPD-1 Conjugate in Patients With Advanced MalignanciesNot yet recruitingNCT06528249Phase 1
- Pharmacogenomics for Better Treatment of Fungal Infections Clinical TrialRecruitingNCT06510699Phase 2
- Rehabilitation Needs for Hematologic Cancer Candidate for Hematopoietic Stem Cell Transplantation or CAR T-Cell TherapyNot yet recruitingNCT06506396
- CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological TumorsRecruitingNCT06503094Phase 1/2
- Increasing Knowledge and Interest in Cancer Clinical TrialsRecruitingNCT06501040Not applicable
- An Epidemiological Study to Investigate the Characteristics of RSV Infection in Adult Hematopoietic Cell Transplant Recipients or Hematological Malignancies Patients in Tianjin HI (Hematology Institute)RecruitingNCT06490549
- HEME Home Transfusion ProgramRecruitingNCT06487247Not applicable
- TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic MalignanciesRecruitingNCT06484816Phase 1
- Take the Reins: The Effects of Nutrient Timing on Cancer-related FatigueRecruitingNCT06482515Phase 2
- Seen and Be Heard: Ensuring Fair Cancer Care for All ChildrenNot yet recruitingNCT06481527
- Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic DiseasesNot yet recruitingNCT06480630Phase 2
- BMT-CARE: Psychosocial Intervention for Transplant CaregiversRecruitingNCT06472089Not applicable
- Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)RecruitingNCT06469307Not applicable
- Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies Previously Enrolled in Studies With TafasitamabRecruitingNCT06465433Phase 2